Analgesia
Conditions
Brief summary
The aim of this study was to compare the postpartum recovery of pregnant women who had vaginal delivery with and without neuraxial labor analgesia using the ObsQoR-10 scoring system.
Detailed description
In this study, we planned to conduct a study to compare the postpartum recovery of pregnant women according to patient-reported outcome measures using the ObsQoR-10 score in vaginal deliveries with and without neuraxial labor analgesia (dural puncture epidural or combined spino epidural analgesia). In this study, after obtaining the approval of the ethics committee of Atatürk University Faculty of Medicine Hospital and written informed consent of the patients, 40 pregnant women who will deliver vaginally with or without neuraxial analgesia will be prospectively enrolled. Patients will be randomized by a statistician using a computerized random numbers table and divided into 2 equal groups as Group A and Group B. Pregnant women in Group A will receive neuraxial labor analgesia (dural puncture epidural or combined spino epidural analgesia), while Group B will not. If postpartum analgesic needs arise, patients in Group A will receive 0.0625% bupivacaine via epidural route, while pregnant women in Group B will receive iboprufen and acetaminophen if needed. ObsQoR-10 scores of the postpartum patients will be evaluated and recorded at discharge. In addition, basic demographic information and medical, analgesic and obstetric parameters related to the peripartum period will be recorded.
Interventions
PROCEDURElabor with neuraxial labor analgesia
Pregnant women in Group A will receive neuraxial labor analgesia (dural puncture epidural or combined spino epidural analgesia). If postpartum analgesic needs arise, patients in Group A will receive 0.0625% bupivacaine via epidural route.
PROCEDURElabour without noroaxial labor analgesia
Pregnant women in Group B will not receive neuraxial labor analgesia (dural puncture epidural or combined spino epidural analgesia). If postpartum analgesic needs arise, patients in Group B will receive iboprufen and acetaminophen.
Sponsors
Ataturk University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes
Inclusion criteria
* Being ≥18 years old * Pregnant women consenting to neuraxial analgesia for labor * Being ≥37 weeks gestation
Exclusion criteria
* Patients in whom neuraxial analgesia is contraindicated * Being \<18 years old * Being \<37 weeks gestation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| ObsQoR-10 scores of postpartum patients | Patients' ObsQoR-10 scores will be determined at 24 hours postpartum | ObsQoR-10 scores of postpartum patients will be recorded before discharge |
Countries
Turkey (Türkiye)
Contacts
Primary ContactAyşenur Dostbil
Backup ContactAyşenur Dostbil
Outcome results
None listed